Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase

Details for Australian Patent Application No. 2007206942 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Gaurrand, Sandrine Francoise Dominique; Angibaud, Patrick Rene; Marconnet-Decrane, Laurence Francoise Bernadette

Agent Shelston IP

Pub. Number AU-B-2007206942

PCT Pub. Number WO2007/082874

Priority 06100570.8 19.01.06 EP

Filing date 16 January 2007

Wipo publication date 26 July 2007

Acceptance publication date 23 August 2012

International Classifications

C07D 239/42 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/506 - not condensed and containing further heterocyclic rings

A61P 35/00 Antineoplastic agents

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 409/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

28 August 2008 PCT application entered the National Phase

  PCT publication WO2007/082874 Priority application(s): WO2007/082874

23 August 2012 Application Accepted

  Published as AU-B-2007206942

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007206944-Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase

2007206941-Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase